Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Fish Shellfish Immunol ; 93: 934-939, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31404633

ABSTRACT

Tightened regulations and an environmentally friendly approaches in fish production have greatly reduced the use of antibiotics but green solutions are continuously being explored. The use of functional feed may have a potential in the aquaculture sector in securing biomass and minimizing the loss from disease. In the present study, we tested the concept that blood from the fish slaughterhouse can be used for mass purification of specific antibodies which subsequently can be used for feeding fish and thereby confer protection against diseases. IgM was purified from serum from Yersinia ruckeri vaccinated rainbow trout and an IgM sandwich ELISA was developed for quantification of rainbow trout IgM. The purified IgM was encapsulated in alginate microparticles and top-coated in fish feed. IgM re-extracted from the alginate microparticles was shown to retain high reactivity towards Y. ruckeri antigens indicating that its bioactivity remained intact after encapsulation. IgM release from the alginate microparticles was only observed at high pH (pH 8.2) and minimal at low pH, indicating protection of IgM at low pH in the fish stomach during passage. In a feeding - challenge experiment (feeding 1 week before Y. ruckeri challenge and for two weeks following challenge), a statistically non-significant 10% lower mortality was observed in the high dose (400 µg IgM/fish/day fed over 3 weeks) group.


Subject(s)
Fish Diseases/immunology , Immunoglobulin M/metabolism , Oncorhynchus mykiss/immunology , Protective Agents/metabolism , Yersinia Infections/veterinary , Yersinia ruckeri/drug effects , Animal Feed/analysis , Animals , Diet/veterinary , Dietary Supplements/analysis , Fish Diseases/drug therapy , Immunoglobulin M/administration & dosage , Protective Agents/administration & dosage , Yersinia Infections/drug therapy , Yersinia Infections/immunology
2.
PLoS One ; 11(1): e0147373, 2016.
Article in English | MEDLINE | ID: mdl-26824607

ABSTRACT

There is an increasing demand for non-antibiotics solutions to control infectious disease in intensive pig production. Here, one such alternative, namely pig antibodies purified from slaughterhouse blood was investigated in order to elucidate its potential usability to control post-weaning diarrhoea (PWD), which is one of the top indications for antibiotics usage in the pig production. A very cost-efficient and rapid one-step expanded bed adsorption (EBA) chromatography procedure was used to purify pig immunoglobulin G from slaughterhouse pig plasma (more than 100 litres), resulting in >85% pure pig IgG (ppIgG). The ppIgG thus comprised natural pig immunoglobulins and was subsequently shown to contain activity towards four pig-relevant bacterial strains (three different types of Escherichia coli and one type of Salmonella enterica) but not towards a fish pathogen (Yersinia ruckeri), and was demonstrated to inhibit the binding of the four pig relevant bacteria to a pig intestinal cell line (IPEC-J2). Finally it was demonstrated in an in vivo weaning piglet model for intestinal colonization with an E. coli F4+ challenge strain that ppIgG given in the feed significantly reduced shedding of the challenge strain, reduced the proportion of the bacterial family Enterobacteriaceae, increased the proportion of families Enterococcoceae and Streptococcaceae and generally increased ileal microbiota diversity. Conclusively, our data support the idea that natural IgG directly purified from pig plasma and given as a feed supplement can be used in modern swine production as an efficient and cost-effective means for reducing both occurrence of PWD and antibiotics usage and with a potential for the prevention and treatment of other intestinal infectious diseases even if the causative agent might not be known.


Subject(s)
Anti-Bacterial Agents/pharmacology , Diarrhea/veterinary , Dietary Supplements , Escherichia coli Infections/veterinary , Immunoglobulin G/pharmacology , Intestinal Diseases/veterinary , Swine Diseases/prevention & control , Animal Feed , Animals , Animals, Newborn , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/isolation & purification , Bacterial Adhesion/drug effects , Biodiversity , Cell Line , Diarrhea/immunology , Diarrhea/microbiology , Diarrhea/prevention & control , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/microbiology , Escherichia coli/drug effects , Escherichia coli/growth & development , Escherichia coli Infections/immunology , Escherichia coli Infections/microbiology , Escherichia coli Infections/prevention & control , Immunoglobulin G/blood , Immunoglobulin G/isolation & purification , Intestinal Diseases/immunology , Intestinal Diseases/microbiology , Intestinal Diseases/prevention & control , Intestines/drug effects , Intestines/immunology , Intestines/microbiology , Microbial Sensitivity Tests , Microbiota/drug effects , Salmonella enterica/drug effects , Salmonella enterica/growth & development , Swine , Swine Diseases/immunology , Swine Diseases/microbiology , Weaning , Yersinia ruckeri/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL